We are live on !
Find out more
RNS
Robert N. Shapiro Portfolio holdings
AUM
$501M
Turnover
13.22%
1-Year Est. Return
11.71%
This Fund
S&P 500
This Quarter Est. Return
+4.89%
1 Year Est. Return
+11.71%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$526M
AUM Growth
-$15M
(-2.8%)
Cap. Flow
-$37.5M
Cap. Flow % of AUM
Cap. Flow %
-7.12%
Top 10 Holdings %
Top 10 Hldgs %
20.82%
Holding
838
New
68
Increased
103
Reduced
223
Closed
70
Avg Time Held
0.8
years
Top 10 Avg Time Held
0.8
years
Top 20 Avg Time Held
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$4.07M |
| 2 |
Progressive
PGR
|
+$1.69M |
| 3 |
Ross Stores
ROST
|
+$1.49M |
| 4 |
RPM International
RPM
|
+$1M |
| 5 |
CME Group
CME
|
+$603K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ironwood Pharmaceuticals
IRWD
|
+$4.61M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$4.18M |
| 3 |
IBM
IBM
|
+$3.38M |
| 4 |
Walmart Inc
WMT
|
+$2.64M |
| 5 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$2.05M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.36% |
| 2 | Miscellaneous | 13.39% |
| 3 | Energy | 13.3% |
| 4 | Technology | 12.81% |
| 5 | Industrials | 12.54% |
Similar funds
LOM
ABI
AGCJ
ACM
NTP
CAMI
Robert N. Shapiro's Q2 2014 Portfolio in Review
As of Q2 2014, Robert N. Shapiro held 838 positions worth $526M, down 2.8% from $541M the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Robert N. Shapiro withdrew a net $37.5M in Q2 2014, closing 70 positions and reducing 223 holdings. Its most notable exit was Willis Towers Watson, an estimated $1.18M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 15% a quarter earlier, followed by Miscellaneous and Energy.
Against the trend, Robert N. Shapiro opened a new position in Progressive worth $1.73M.
- Robert N. Shapiro's largest Q2 2014 buy was Progressive: 68,380 shares worth $1.73M.
- Robert N. Shapiro added most to Vanguard FTSE Developed Markets ETF in Q2 2014, an estimated $4.07M increase.
- Robert N. Shapiro's biggest Q2 2014 reduction was Ironwood Pharmaceuticals, cutting an estimated $4.61M.
- Robert N. Shapiro fully exited Willis Towers Watson in Q2 2014, selling an estimated $1.18M.
- Robert N. Shapiro's ten largest holdings make up 21% of its $526M portfolio in Q2 2014.
- Robert N. Shapiro opened 68 new positions and closed 70 in Q2 2014.
- Robert N. Shapiro's portfolio value fell 2.8% quarter-over-quarter to $526M.
Based on Robert N. Shapiro's 13F filing for Q2 2014, filed 11 Sep 2014.